Amgen Inc at Wells Fargo Healthcare Conference Transcript
Awesome. Thank you very much for joining us again today. My name is Mohit Bansal. I am one of the biotech and pharma analysts here at Wells Fargo, and I have a pleasure to introduce Amgen management team with us today.
So we have Thomas Dittrich, Chief Financial Officer of the company. We have Paul Burton, the Chief Medical Officer of the company. We have Kave, he is the SVP Global Marketing and Access. And Casey, you all know, he is the Head of IR at Amgen. And thank you very much team Amgen for joining us today. And I'll give the podium to Thomas for prepared remarks.
Thank you, Mohit. It's really good to be here. And before we get into Q&A, I would like to take some time to introduce myself briefly and share a few thoughts on how we see the business today. As many of you know, it's actually my second chapter at Amgen. I spent nearly a decade here earlier in my career working very closely with Bob and with the team at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
